Sage Therapeutics Stock Rockets on Two Positive Phase III Trials in Postpartum Depression Post author:Sam Post published:November 8, 2017 Post category:BioPharma The positive results support the company’s planned regulatory submissions. Source: BioSpace You Might Also Like ImmunoCellular Therapeutics To Report Fourth Quarter And Full Year 2016 Financial Results On March 9, 2017 March 6, 2017 Martin Shkreli Ordered to Forfeit $7.36 Million in Assets Ahead of Sentencing March 5, 2018 Vertex Quietly Terminates a Small Phase II CF Trial September 11, 2017
ImmunoCellular Therapeutics To Report Fourth Quarter And Full Year 2016 Financial Results On March 9, 2017 March 6, 2017
